<SEC-DOCUMENT>0001136261-16-000539.txt : 20160705
<SEC-HEADER>0001136261-16-000539.hdr.sgml : 20160705
<ACCEPTANCE-DATETIME>20160705163119
ACCESSION NUMBER:		0001136261-16-000539
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160701
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20160705
DATE AS OF CHANGE:		20160705

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tiger X Medical, Inc.
		CENTRAL INDEX KEY:			0000925741
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				232753988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21419
		FILM NUMBER:		161750894

	BUSINESS ADDRESS:	
		STREET 1:		10900 WILSHIRE BOULEVARD, SUITE #1500
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024
		BUSINESS PHONE:		(310) 987-7345

	MAIL ADDRESS:	
		STREET 1:		10900 WILSHIRE BOULEVARD, SUITE #1500
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardo Medical, Inc.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLICKNSETTLE COM INC
		DATE OF NAME CHANGE:	20000823

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NAM CORP
		DATE OF NAME CHANGE:	19960802
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>body8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>July 5, 2016 8K DOC</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">
<FONT FACE="Times New Roman" SIZE="2">




<DIV align=left>
<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">
</DIV>

<FONT SIZE="3"><B><P ALIGN="CENTER">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549</P></FONT></B>


<HR align=center SIZE=2 width="25%">
<BR>
<FONT SIZE="4"><B><P ALIGN="CENTER">FORM 8-K</P></FONT></B>
<HR align=center SIZE=2 width="25%">



<B><P ALIGN="CENTER">CURRENT REPORT<BR> &nbsp;  <BR>
</B> Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</P>

<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 ALIGN="CENTER" WIDTH=35%>
<TR><TD WIDTH="61%" VALIGN="TOP">
<FONT SIZE=2><P>Date of Report (Date of Earliest Event Reported):</FONT></TD>
<TD WIDTH="39%" VALIGN="TOP">
<FONT SIZE=2><P>July 1, 2016</FONT></TD>
</TR>
</TABLE>

<B><P ALIGN="CENTER">Tiger X Medical, Inc.</P>
</B><P ALIGN="CENTER">(Exact name of registrant as specified in its charter)</P>
<P ALIGN="CENTER">________________</P>

<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD WIDTH="33%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">Delaware<BR>
</U> (State or other jurisdiction<BR>
   of incorporation)</FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">0-21419<BR>
</U>                  (Commission<BR>
                  File Number)</FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">23-2753988<BR>
</U>                   (I.R.S. Employer<BR>
                  Identification No.)</P>
</FONT></TD>
</TR>
</TABLE>
</CENTER></P>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=583>
<TR><TD WIDTH="64%" VALIGN="TOP">
<U><FONT SIZE=2><P>       2934&frac12; Beverly Glen Circle, Suite 203, Los Angeles, California<BR>
</U>                  (Address of principal executive offices)</FONT></TD>
<TD WIDTH="36%" VALIGN="TOP">
<U><FONT SIZE=2><P ALIGN="CENTER">90077<BR>
</U>                   (Zip Code)</FONT></TD>
</TR>
</TABLE>
</CENTER></P>


<P ALIGN="CENTER">Registrant's telephone number, including area code: 310-987-7345</P>

<U><P ALIGN="CENTER">Not Applicable</U><BR>
              Former name or former address, if changed since last report</P>
<P ALIGN="CENTER">________________</P>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Written
communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Soliciting material
pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

<DIV align=left>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">
</DIV>
<P style="PAGE-BREAK-BEFORE: always" align=left>



<B><FONT SIZE=2>



<P>Item 8.01 &nbsp;&nbsp; Other Events.</P></B>


<FONT SIZE=2><P>On July 1, 2016, Tiger X Medical, Inc. (the "Company") completed the previously announced transaction pursuant to a Royalty Settlement and Release
Agreement ("Agreement") by and among the Company, Tiger X Medical, LLC, a wholly owned subsidiary of the Company ("Tiger LLC" and together with the Company, the
"Sellers"), and Arthrex, Inc. (the "Buyer") pursuant to which the Buyer paid the Company $5,642,302 on July 1, 2016 as a royalty payment ("Royalty Payment") in full satisfaction of
all amounts due or payable or which could become due or payable to the Company under a previously disclosed Asset Purchase Agreement ("APA"), dated January 24, 2011, by
and among the Sellers and Buyer. As previously disclosed and pursuant to the Agreement, all obligations and  liabilities relating to the APA were unconditionally and irrevocably
terminated and released except for the Royalty Payment. The Sellers and Buyer each unconditionally and irrevocably released and covenanted not to bring any suit, claim or
proceeding against the other party. As of May 5, 2016, the Buyer and Seller agreed they would no longer be entitled to exercise any rights or interest relating to the APA, except for
certain surviving provisions of the APA.</P>


<P> &nbsp; </P>
<P> &nbsp; </P>
<P> &nbsp; </P>


<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" ALIGN=left>


<B><P ALIGN="CENTER">SIGNATURES</P>
</B><P ALIGN="JUSTIFY">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=686>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">July 5, 2016</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<B><FONT SIZE=2><P ALIGN="JUSTIFY">Tiger X Medical, Inc.</P>
</B><P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">By:&#9;<U>/s/ Steven Rubin&#9;&#9;&#9;<BR>
</U>      Name:&#9;Steven Rubin<BR>
                   Title:&#9;Interim Chief Executive Officer</FONT></TD>
</TR>
</TABLE>

<FONT SIZE=2>

<P> &nbsp; </P>
<P> &nbsp; </P>

<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" ALIGN=left>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
